Our CEO, Bruce Hellman, joins Jennifer Goldsack, Executive Director at Digital Medicine Society (DiMe), and Deepak Bandyopadhyay, Associate Director of Quality Analytics at Janssen Inc., for an AI-focused Q&A.
Read the full article here: Will Artificial Intelligence revolutionise clinical trials?
